Cargando…
The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives
Artificial intelligence (AI) and machine learning (ML) represent significant advancements in computing, building on technologies that humanity has developed over millions of years—from the abacus to quantum computers. These tools have reached a pivotal moment in their development. In 2021 alone, the...
Autor principal: | Niazi, Sarfaraz K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493153/ https://www.ncbi.nlm.nih.gov/pubmed/37701048 http://dx.doi.org/10.2147/DDDT.S424991 |
Ejemplares similares
-
Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
por: Geerts, H, et al.
Publicado: (2012) -
Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
por: Niazi, Sarfaraz
Publicado: (2022) -
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015) -
Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug
Development
por: Fermini, Bernard, et al.
Publicado: (2018) -
The AI for Scientific Discovery Network(+)
por: Kanza, Samantha, et al.
Publicado: (2021)